SDF-1 gamma (Neuraxo Biopharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameSDF-1 gamma (Neuraxo Biopharmaceuticals)
Drug Alias Namestromal cell-derived factor-1 gamma (Neuraxo Biopharmaceuticals)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionC-X-C motif chemokine ligand 12 stimulants
TargetsC-X-C motif chemokine ligand 12
Therapy Area/IndicationsSpinal Cord Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSpinal Cord Therapeutics GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsSpinal Cord Injuries

Other Information

ATC CodeN/A
Related LinksN/A